{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:01:12Z","timestamp":1784127672001,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12931-015-0244-0","type":"journal-article","created":{"date-parts":[[2015,7,31]],"date-time":"2015-07-31T16:09:32Z","timestamp":1438358972000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Building a better neonatal mouse model to understand infant respiratory syncytial virus disease"],"prefix":"10.1186","volume":"16","author":[{"given":"Dahui","family":"You","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Siefker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bishwas","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordy","family":"Saravia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephania A.","family":"Cormier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,1]]},"reference":[{"key":"244_CR1","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","volume":"375","author":"H Nair","year":"2010","unstructured":"Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375:1545\u201355.","journal-title":"Lancet"},{"key":"244_CR2","doi-asserted-by":"publisher","first-page":"010401","DOI":"10.7189\/jogh.03.010101","volume":"3","author":"I Rudan","year":"2013","unstructured":"Rudan I, O\u2019Brien KL, Nair H, Liu L, Theodoratou E, Qazi S, et al. Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries. J Glob Health. 2013;3:010401.","journal-title":"J Glob Health"},{"key":"244_CR3","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1056\/NEJMoa0804877","volume":"360","author":"CB Hall","year":"2009","unstructured":"Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360:588\u201398.","journal-title":"N Engl J Med"},{"key":"244_CR4","doi-asserted-by":"crossref","unstructured":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. Pediatrics. 1998;102:531\u201337.","DOI":"10.1542\/peds.102.3.531"},{"key":"244_CR5","doi-asserted-by":"crossref","unstructured":"Ventre K, Randolph AG. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Cochrane Database Syst Rev. 2007;(1):CD000181.","DOI":"10.1002\/14651858.CD000181.pub3"},{"key":"244_CR6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/oxfordjournals.aje.a120954","volume":"89","author":"AZ Kapikian","year":"1969","unstructured":"Kapikian AZ, Mitchell RH, Chanock RM, Shvedoff RA, Stewart CE. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am J Epidemiol. 1969;89:405\u201321.","journal-title":"Am J Epidemiol"},{"key":"244_CR7","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","volume":"89","author":"HW Kim","year":"1969","unstructured":"Kim HW, Canchola JG, Brandt CD, Pyles G, Chanock RM, Jensen K, et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol. 1969;89:422\u201334.","journal-title":"Am J Epidemiol"},{"key":"244_CR8","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1086\/516152","volume":"25","author":"LG Byrd","year":"1997","unstructured":"Byrd LG, Prince GA. Animal models of respiratory syncytial virus infection. Clin Infect Dis. 1997;25:1363\u20138.","journal-title":"Clin Infect Dis"},{"key":"244_CR9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1465-9921-7-107","volume":"7","author":"D You","year":"2006","unstructured":"You D, Becnel D, Wang K, Ripple M, Daly M, Cormier SA. Exposure of neonates to respiratory syncytial virus is critical in determining subsequent airway response in adults. Respir Res. 2006;7:107.","journal-title":"Respir Res"},{"key":"244_CR10","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1084\/jem.20020943","volume":"196","author":"FJ Culley","year":"2002","unstructured":"Culley FJ, Pollott J, Openshaw PJ. Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood. J Exp Med. 2002;196:1381\u20136.","journal-title":"J Exp Med"},{"key":"244_CR11","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.4049\/jimmunol.175.3.1876","volume":"175","author":"A Dakhama","year":"2005","unstructured":"Dakhama A, Park JW, Taube C, Joetham A, Balhorn A, Miyahara N, et al. The enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and IL-13 production. J Immunol. 2005;175:1876\u201383.","journal-title":"J Immunol"},{"key":"244_CR12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/1465-9921-6-122","volume":"6","author":"D Becnel","year":"2005","unstructured":"Becnel D, You D, Erskin J, Dimina DM, Cormier SA. A role for airway remodeling during respiratory syncytial virus infection. Respir Res. 2005;6:122.","journal-title":"Respir Res"},{"key":"244_CR13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/modpathol.3800725","volume":"20","author":"JE Johnson","year":"2007","unstructured":"Johnson JE, Gonzales RA, Olson SJ, Wright PF, Graham BS. The histopathology of fatal untreated human respiratory syncytial virus infection. Mod Pathol. 2007;20:108\u201319.","journal-title":"Mod Pathol"},{"key":"244_CR14","doi-asserted-by":"publisher","first-page":"L148","DOI":"10.1152\/ajplung.00065.2011","volume":"301","author":"RA Bem","year":"2011","unstructured":"Bem RA, Domachowske JB, Rosenberg HF. Animal models of human respiratory syncytial virus disease. Am J Physiol Lung Cell Mol Physiol. 2011;301:L148\u201356.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"244_CR15","first-page":"281","volume":"66","author":"R Chanock","year":"1957","unstructured":"Chanock R, Roizman B, Myers R. Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). I. Isolation, properties and characterization. Am J Hyg. 1957;66:281\u201390.","journal-title":"Am J Hyg"},{"key":"244_CR16","first-page":"234","volume":"74","author":"AZ Kapikian","year":"1961","unstructured":"Kapikian AZ, Bell JA, Mastrota FM, Johnson KM, Huebner RJ, Chanock RM. An outbreak of febrile illness and pneumonia associated with respiratory syncytial virus infection. Am J Hyg. 1961;74:234\u201348.","journal-title":"Am J Hyg"},{"key":"244_CR17","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.1128\/JVI.01853-08","volume":"83","author":"ML Moore","year":"2009","unstructured":"Moore ML, Chi MH, Luongo C, Lukacs NW, Polosukhin VV, Huckabee MM, et al. A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction. J Virol. 2009;83:4185\u201394.","journal-title":"J Virol"},{"key":"244_CR18","doi-asserted-by":"publisher","first-page":"977","DOI":"10.2353\/ajpath.2006.051055","volume":"169","author":"NW Lukacs","year":"2006","unstructured":"Lukacs NW, Moore ML, Rudd BD, Berlin AA, Collins RD, Olson SJ, et al. Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus. Am J Pathol. 2006;169:977\u201386.","journal-title":"Am J Pathol"},{"key":"244_CR19","first-page":"Unit26.26","volume":"Chapter 26","author":"MS Boukhvalova","year":"2010","unstructured":"Boukhvalova MS, Yim KC, Prince GA, Blanco JC. Methods for monitoring dynamics of pulmonary RSV replication by viral culture and by real-time reverse transcription-PCR in vivo: detection of abortive viral replication. Curr Protoc Cell Biol. 2010;Chapter 26:Unit26.26.","journal-title":"Curr Protoc Cell Biol"},{"key":"244_CR20","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/BF01863914","volume":"162","author":"G K\u00e4rber","year":"1931","unstructured":"K\u00e4rber G. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1931;162:480\u20133.","journal-title":"Naunyn Schmiedebergs Arch Exp Pathol Pharmakol"},{"key":"244_CR21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.2044-8295.1908.tb00176.x","volume":"2","author":"C Spearman","year":"1908","unstructured":"Spearman C. The method of \u2018Right and Wrong Cases\u2019 (\u2018Constant Stimuli\u2019) without gauss\u2019s formulae. Br J Psychol 1904\u20131920. 1908;2:227\u201342.","journal-title":"Br J Psychol 1904\u20131920"},{"key":"244_CR22","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1086\/430008","volume":"191","author":"JP DeVincenzo","year":"2005","unstructured":"DeVincenzo JP, El Saleeby CM, Bush AJ. Respiratory syncytial virus load predicts disease severity in previously healthy infants. J Infect Dis. 2005;191:1861\u20138.","journal-title":"J Infect Dis"},{"key":"244_CR23","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1164\/rccm.201002-0221OC","volume":"182","author":"JP DeVincenzo","year":"2010","unstructured":"DeVincenzo JP, Wilkinson T, Vaishnaw A, Cehelsky J, Meyers R, Nochur S, et al. Viral load drives disease in humans experimentally infected with respiratory syncytial virus. Am J Respir Crit Care Med. 2010;182:1305\u201314.","journal-title":"Am J Respir Crit Care Med"},{"key":"244_CR24","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1586\/eri.10.125","volume":"8","author":"SA Cormier","year":"2010","unstructured":"Cormier SA, You D, Honnegowda S. The use of a neonatal mouse model to study respiratory syncytial virus infections. Expert Rev Anti Infect Ther. 2010;8:1371\u201380.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"244_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040499","volume":"7","author":"KM Empey","year":"2012","unstructured":"Empey KM, Orend JG, Peebles Jr RS, Egana L, Norris KA, Oury TD, et al. Stimulation of immature lung macrophages with intranasal interferon gamma in a novel neonatal mouse model of respiratory syncytial virus infection. PLoS One. 2012;7:e40499.","journal-title":"PLoS One"},{"key":"244_CR26","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1128\/CMR.18.3.541-555.2005","volume":"18","author":"PJ Openshaw","year":"2005","unstructured":"Openshaw PJ, Tregoning JS. Immune responses and disease enhancement during respiratory syncytial virus infection. Clin Microbiol Rev. 2005;18:541\u201355.","journal-title":"Clin Microbiol Rev"},{"key":"244_CR27","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/ppul.10101","volume":"33","author":"KJ Mobbs","year":"2002","unstructured":"Mobbs KJ, Smyth RL, O\u2019Hea U, Ashby D, Ritson P, Hart CA. Cytokines in severe respiratory syncytial virus bronchiolitis. Pediatr Pulmonol. 2002;33:449\u201352.","journal-title":"Pediatr Pulmonol"},{"key":"244_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s004310000676","volume":"160","author":"RY Sung","year":"2001","unstructured":"Sung RY, Hui SH, Wong CK, Lam CW, Yin J. A comparison of cytokine responses in respiratory syncytial virus and influenza A infections in infants. Eur J Pediatr. 2001;160:117\u201322.","journal-title":"Eur J Pediatr"},{"key":"244_CR29","doi-asserted-by":"publisher","first-page":"4804","DOI":"10.4049\/jimmunol.1000484","volume":"185","author":"MJ Ripple","year":"2010","unstructured":"Ripple MJ, You D, Honnegowda S, Giaimo JD, Sewell AB, Becnel DM, et al. Immunomodulation with IL-4R alpha antisense oligonucleotide prevents respiratory syncytial virus-mediated pulmonary disease. J Immunol. 2010;185:4804\u201311.","journal-title":"J Immunol"},{"key":"244_CR30","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1189\/jlb.1012498","volume":"93","author":"D You","year":"2013","unstructured":"You D, Marr N, Saravia J, Shrestha B, Lee GI, Turvey SE, et al. IL-4Ralpha on CD4+ T cells plays a pathogenic role in respiratory syncytial virus reinfection in mice infected initially as neonates. J Leukoc Biol. 2013;93:933\u201342.","journal-title":"J Leukoc Biol"},{"key":"244_CR31","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.jaci.2012.08.033","volume":"130","author":"J Han","year":"2012","unstructured":"Han J, Dakhama A, Jia Y, Wang M, Zeng W, Takeda K, et al. Responsiveness to respiratory syncytial virus in neonates is mediated through thymic stromal lymphopoietin and OX40 ligand. J Allergy Clin Immunol. 2012;130:1175\u201386.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"244_CR32","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1128\/JVI.02472-14","volume":"89","author":"AL Hotard","year":"2014","unstructured":"Hotard AL, Lee S, Currier MG, Crowe Jr JE, Sakamoto K, Newcomb DC, et al. Identification of residues in the human respiratory syncytial virus fusion protein that modulate fusion activity and pathogenesis. J Virol. 2014;89(1):512\u201322.","journal-title":"J Virol"},{"key":"244_CR33","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1136\/adc.88.10.922","volume":"88","author":"PS McNamara","year":"2003","unstructured":"McNamara PS, Ritson P, Selby A, Hart CA, Smyth RL. Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis. Arch Dis Child. 2003;88:922\u20136.","journal-title":"Arch Dis Child"},{"key":"244_CR34","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1086\/512615","volume":"195","author":"TP Welliver","year":"2007","unstructured":"Welliver TP, Garofalo RP, Hosakote Y, Hintz KH, Avendano L, Sanchez K, et al. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis. 2007;195:1126\u201336.","journal-title":"J Infect Dis"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12931-015-0244-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-015-0244-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-015-0244-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-015-0244-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T18:20:17Z","timestamp":1630606817000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-015-0244-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["244"],"URL":"https:\/\/doi.org\/10.1186\/s12931-015-0244-0","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,1]]},"assertion":[{"value":"16 December 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"91"}}